Agilon Health, Inc.
AGL · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,061 | $4,316 | $2,388 | $1,521 |
| % Growth | 40.4% | 80.7% | 57% | – |
| Cost of Goods Sold | $6,056 | $4,247 | $2,277 | $1,456 |
| Gross Profit | $5 | $70 | $111 | $66 |
| % Margin | 0.1% | 1.6% | 4.7% | 4.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $269 | $286 | $208 | $428 |
| SG&A Expenses | $269 | $286 | $208 | $428 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $28 | $16 | $9 | $10 |
| Operating Expenses | $297 | $302 | $217 | $438 |
| Operating Income | -$292 | -$232 | -$105 | -$372 |
| % Margin | -4.8% | -5.4% | -4.4% | -24.5% |
| Other Income/Exp. Net | $43 | $38 | $15 | -$11 |
| Pre-Tax Income | -$249 | -$194 | -$91 | -$383 |
| Tax Expense | $1 | $1 | $2 | $1 |
| Net Income | -$260 | -$263 | -$107 | -$406 |
| % Margin | -4.3% | -6.1% | -4.5% | -26.7% |
| EPS | -0.63 | -0.64 | -0.26 | -1.09 |
| % Growth | 1.6% | -146.2% | 76.1% | – |
| EPS Diluted | -0.63 | -0.64 | -0.26 | -1.09 |
| Weighted Avg Shares Out | 411 | 409 | 408 | 373 |
| Weighted Avg Shares Out Dil | 411 | 409 | 408 | 373 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6 | $7 | $4 | $6 |
| Depreciation & Amortization | $24 | $20 | $14 | $15 |
| EBITDA | -$218 | -$168 | -$72 | -$362 |
| % Margin | -3.6% | -3.9% | -3% | -23.8% |